Details for New Drug Application (NDA): 209708
✉ Email this page to a colleague
NDA 209708 describes MIVACURIUM CHLORIDE, which is a drug marketed by Rising and Woodward and is included in two NDAs. Additional details are available on the MIVACURIUM CHLORIDE profile page.
The generic ingredient in MIVACURIUM CHLORIDE is mivacurium chloride. There are two drug master file entries for this compound. Additional details are available on the mivacurium chloride profile page.
The generic ingredient in MIVACURIUM CHLORIDE is mivacurium chloride. There are two drug master file entries for this compound. Additional details are available on the mivacurium chloride profile page.
Summary for 209708
| Tradename: | MIVACURIUM CHLORIDE |
| Applicant: | Woodward |
| Ingredient: | mivacurium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 10MG BASE/5ML (EQ 2MG BASE/ML) | ||||
| Approval Date: | Oct 12, 2021 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | EQ 20MG BASE/10ML (EQ 2MG BASE/ML) | ||||
| Approval Date: | Oct 12, 2021 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
